Buy Apteki 36,6 (APTK) shares: price today, chart, and live stats
              Moscow Exchange

              Apteki 36,6

              Common stockAPTK

              Apteki 36,6 is a public company whose securities are admitted to trading on Moscow Exchange. Equity type: Common stock, ticker: APTK.
              The security is in the Level 2 List, confirming its compliance with the MOEX requirements. Standard lot size: 10. Trade currency: RUB.
              ISIN: RU0008081765.

              Stock price dynamics

              Common stock
              APTK
              Trading data is displayed with a delay of 15 minutes.
              Please subscribe
               to receive real-time market data
              Daily

              Trading volume

              -

              Day's Range

              -

              Value of equity

              -

              Trading data is displayed with a delay of 15 minutes

              Overview

              End-of-Day Data
              Security code
              APTK
              Trading Mode ID
              TQBR
              Trading Mode Name
              T+: stocks, DRs - order-driven
              Qualified investors
              No
              Full name
              Apteki 36,6
              Short name
              Apteki 36,6
              State registration number
              1-01-07335-A
              Face value
              0.64
              Face value currency
              RUB
              Issue Size
              7,630,433,826
              ISIN Code
              RU0008081765
              List level
              2
              Lot
              10
              Date of listing
              21.12.2005
              Admission to the morning additional trading session
              Yes
              Admission to the evening additional trading session
              Yes
              Admission to the weekend additional trading session
              Yes
              Security
              A
              Group of Instruments
              EQIN
              Trade settle date
              23.09.2026

              More About the Issuer

              Issuer Profile
              Name
              PJSC "Pharmacy Chain 36,6"
              Taxpayer ID
              7722266450
              Company website
              Issuer Reporting
              Disclosure Violations
              Issuer Credit Rating
              Name of Credit Rating Agency
              Rating
              Outlook
              Press release
              ACRA
              BBB+(RU)
              05.12.2026
              Credit Watch
              Expert NRA
              BBB+|ru|
              08.20.2026
              Stable
              ACRA
              Rating
              BBB+(RU)
              Rating date
              05.12.2026
              Outlook
              Credit Watch
              Press release
              Expert NRA
              Rating
              BBB+|ru|
              Rating date
              08.20.2026
              Outlook
              Stable
              Press release
              The data provided by
              www.acra-ratings.ru
              ...
              View
              Financials
              Parameter
              Net profit (loss) attributable to owners of the parent
              Earnings Per Share (EPS)
              Interest Income
              Assets
              Equity
              ROA
              Debt/EBITDA
              2025
              2024
              2023
              263 млн. руб.
              267 млн. руб.
              120 млн. руб.
              0.04 руб.
              0.04 руб.
              0.02 руб.
              179 млн. руб.
              346 млн. руб.
              283 млн. руб.
              64,130 млн. руб.
              60,786 млн. руб.
              53,218 млн. руб.
              -7,301 млн. руб.
              -7,564 млн. руб.
              -6,831 млн. руб.
              0.410104%
              0.439246%
              0.225488%
              1.864322
              2.101549
              2.455498
              Net profit (loss) attributable to owners of the parent
              2025
              263 млн. руб.
              2024
              267 млн. руб.
              2023
              120 млн. руб.
              Earnings Per Share (EPS)
              2025
              0.04 руб.
              2024
              0.04 руб.
              2023
              0.02 руб.
              Interest Income
              2025
              179 млн. руб.
              2024
              346 млн. руб.
              2023
              283 млн. руб.
              Assets
              2025
              64,130 млн. руб.
              2024
              60,786 млн. руб.
              2023
              53,218 млн. руб.
              Equity
              2025
              -7,301 млн. руб.
              2024
              -7,564 млн. руб.
              2023
              -6,831 млн. руб.
              ROA
              2025
              0.410104%
              2024
              0.439246%
              2023
              0.225488%
              Debt/EBITDA
              2025
              1.864322
              2024
              2.101549
              2023
              2.455498

              Data is provided by the Corporate Information Center with a delay of up to 24 hours (excluding weekends and holidays).

              All information about securities and issuers is provided as part of the Corporate Information Center products

              Get Access

              Investor Help

              Moscow
              Exchange
              School
              Free stock trading course for beginners
              Learn more
              Moscow
              Exchange
              School
              Stock investment analysis course
              Learn more
              Interactive
              Trading
              Calendar
              Schedules of trading and settlement on MOEX's markets
              Go

              Dear website visitors, to submit a suggestion or ask a question, please use the feedback form. We value your opinion and will carefully review all inquiries. Where possible, we will acknowledge receipt of your message and provide a written response. In the event of substantiated and material complaints, the Exchange, together with the Expert Councils, will take steps to develop and implement appropriate changes.​

              Loading, please wait